Cash/Burn From SEC Filing For Period:
Intra-Cellular Therapies is a biopharmaceutical company founded on Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body. We leverage this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. We celebrate science, welcome curiosity, expect collaboration and demand integrity and respect in all we do create and deliver.
Click drug data to see upcoming trial info and prior data
Drug | Disease
Stage | Exp Date
See What The Community Is Saying - Click To See Full Post